Bas van Bussel

Critical Care Physician | Internist | Epidemiologist | Maastricht UMC+

[CARIM @CARIMMaastricht]

Data0: Frank van Rosmalen describes going from a clinical database to a research database to close session 2 of this exciting #CARIMday23.

[Iwan van der Horst @iccvanderhorst]

The future is open. The essential steps to create large datasets was studied and led to recommendations and hopefully more knowledge. Thanks to the collaborators! @JipdeKok @BusselBas @MaastrichtU @CARIMMaastricht
https://t.co/1ImoQivuZA

[Bas van Bussel @BusselBas]

Snel, precies, of allebei de volgende keer?

https://t.co/WgStq3JihA

@carim @MaastrichtUMC #data #corona

[BMJ Global Health @GlobalHealthBMJ]

"We recommend the development of a framework to advise concerns of informed consent and other ethics regulations during times of crisis and in situations with limited resources."

@BusselBas @iccvanderhorst @nick_wilmes

📣 New Research ➡️ https://t.co/ZcWiQzw2nj

[MaastrICCht @cht_ic]

Prediction models developed for COVID-19 now externally validated for ICU: Would those have made a difference ? https://t.co/qiPKdKnN6s

[CARIM @CARIMMaastricht]

This Friday at 08.00 am, Henri Spronk will give the Cardiovascular Grand Rounds lecture: 'Assessment of hyper-coagulability and hypo-fibrinolysis in COVID patients'
@HSpronk @CARIMMaastricht

[MaastrICCht @cht_ic]

Cross-boarder Euregio data collaboration shows that women with Covid have better ICU survival

https://t.co/GBhuXvasPc

@iccvanderhorst @ChahindaGhoss @InterregEMR #covid #gender

[Iwan van der Horst @iccvanderhorst]

Trust, cross-border network, one of those things that evolved during the pandemic @CritCareMed @BusselBas @cht_ic @bickenbach_j https://t.co/JGseIkYF4H
https://t.co/XwIv6qR0JC
https://t.co/nmMV6fjY2i

[MaastrICCht @cht_ic]

The MaastrICCht collaborators evaluated hypercoagulability and hypofibrinolysis in critically ill COVID-19 patients 6 months after ICU discharge. #MaastrICCht
https://t.co/Lhbot8ZTUu

[MaastrICCht @cht_ic]

CoDaP project
Maastricht UMC+ (https://t.co/XocDUJwI2h) has started a large-scale study in the CoDaP project to further map the heterogeneity in Covid patients admitted to the intensive care units funded by INTERREG Euregio Meuse-Rhine and EU.
https://t.co/pS52NQ1xzz

[MaastrICCht @cht_ic]

MaastrICCht collaborators show that lower concentrations of fibrinogen over time may indicate its consumption related to thrombus formation in the pulmonary vessels in severe Covid-19. #MaastrICCht #MUMC
https://t.co/YNTIOnJpeu

[MaastrICCht @cht_ic]

The MaastrIccht collaborators show that physical disability, driven by impaired pulmonary function and skeletal muscle quality, is still common in COVID-19 ICU survivors three months following hospital discharge. https://t.co/9xgvOkn0Bv

[MaastrICCht @cht_ic]

The MaastrICCht collaborators propose the use of global coagulation assays to better assess hemostasis in COVID-19 patients. #MaastrICCht https://t.co/f8Qdre39DE

[MaastrICCht @cht_ic]

MaastrICCht collaborators show persistent hypercoagulability and hypofibrinolysis in severe COVID-19 despite anticoagulation. https://t.co/p1CgrN5HkW

[Bas van Bussel @BusselBas]

@laure_wynants @observantUM @MaartenvSmeden @JochenCals @CarlMoons Proficiat!

[Laure Wynants @laurewynants.bsky.social @laure_wynants]

A panel consisting of covid-19 survivors, laymen, @BusselBas and I translated the findings of our living review of diagnostic and prognostic models for a general audience. https://t.co/Dxa4yj2BEq

[MaastrICCht @cht_ic]

https://t.co/eXJOYL7CVC

[MaastrICCht @cht_ic]

MaastrICCht collaborators show that COVID-19 impacts 3 months after ICU discharge https://t.co/0zrGiEWDHS

[MaastrICCht @cht_ic]

MaastrICCht and CoDaP Euregion collaborators show that more attention for sex differences in Covid-19 is required.

[MaastrICCht @cht_ic]

Results of the Maastricht Intensive Care Covid (MaastrICCht) cohort show that therapeutic anti-coagulation in COVID-19 is challenging.

Twitter: ⁦@cht_ic⁩ https://t.co/RqVysL67p3